None listed
Conditions
Brief summary
The main goal is to gather basic information on how body composition and blood sugar control are connected after a kidney transplant. This information will help in developing future strategies, such as diet, lifestyle changes, or medications, to prevent early metabolic issues and enhance the success of the transplant and the health of the patient
Interventions
This is a prospective cohort study in patients on active kidney transplant list.
Patients will be asked to do the following in addition to their normal transplant work up assessment:
1. Bioimpedance Spectroscopy - non invasive - 5 minutes to complete
2. PG-SGA - malnutrition questionnaire - 5 minutes to complete
3. 24 hr multi pass diet recall - 20 minutes to complete
The patient will be enrolled once on the active transplant list and meet inclusion criteria. We will follow them up until they g
This is a prospective cohort study in patients on active kidney transplant list. Patients will be asked to do the following in addition to their normal transplant work up assessment: 1. Bioimpedance Spectroscopy - non invasive - 5 minutes to complete 2. PG-SGA - malnutrition questionnaire - 5 minutes to complete 3. 24 hr multi pass diet recall - 20 minutes to complete The patient will be enrolled once on the active transplant list and meet inclusion criteria. We will follow them up until they get a transplant - potentially 6 - 24 months depending on when a transplant is available.
Sponsors
Sir Charles Gairdner Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Age 18 years or over Adult transplant recipients able to provide informed consent. Listed for kidney transplantation and subsequently receive a kidney transplant (for the post-transplant analyses) Living or deceased donor kidney transplant recipients. Undergoing transplantation at the Sir Charles Gairdner Hospital Ability to undergo BIS including ability to lie supine and tolerate non-invasive electrical impedance measurements. Willingness and ability to wear a CGM for up to four weeks post-transplant including ability to scan or upload data using a reader or smartphone. Provision of written informed consent obtained pre-transplant while on the active waitlist.
Exclusion criteria
Multi-organ transplantation Inability to safely use CGM including severe dermatological conditions, known allergy to CGM adhesives, or inability to comply with device use. Implanted electronic medical devices incompatible with BIS e.g. certain pacemakers or defibrillators, in line with manufacturer guidance. Inability to provide informed consent including significant cognitive impairment or language barriers not mitigated by interpreter support.
Outcome results
None listed